Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

Innovative diagnostic tools to improve the medical care and the health of Sickle Cell patients : preparing for launch and market access in Europe

Project description

AI to guide treatment for sickle cell disease

Sickle cell disease is a genetic disorder that affects the function red blood cells, leading to a defect to provide oxygen to all the organs. Although some effective treatments exist that reduce disease symptoms, decision-making is difficult and inadequately supported. The mission of the EU-funded INNOVHEM project is to improve clinical care of sickle cell disease patients and improve their quality of life. To achieve this, researchers are developing an artificial intelligence (AI) solution that takes into consideration disease biologocal and clinical parameters to assist physicians in proposing a personalised treatment plan.

Objective

INNOVHEM is a french start-up that has been incorporated in October 2019 which develops new and relevant diagnostic tools to tackle Sickle cell disease. Sickle Cell Disease is a very severe disease and is the most frequent genetic disease over the world, affecting around 5 million people. Despite this disease has been discovered at the beginning of the 20th century, there is still several unmet needs to tackle it.
In resource-poor countries, about 90% of children are estimated to die before the age of 5. In Europe, more than 60 000 people are affected. Their life expectency is shortened to around 45 years old and 80% of physicians say that they lack support tools for treatment decision. In addition, SCD is associated to high clinical costs. At INNOVHEM, we are developing a solution which is a combination of biomarkers, specifically adapted to the physiopathology of the disease, with articial intelligence. This solution will help the physicians to propose a personalized medical care to the patients and it will also help the development of new effective treatments. This will deeply improve health of Sickle cell patients. As an example of impacts, one of the short-term goals is to avoid 20% of emergency visits, this sole effect will save $ 30 million / year in Europe.
During the first year of activity, INNOVHEM showed a high commercial traction, that allows to sign contracts for a total amonut of 800k euros . We also enter into several partnerships with leading clinical and university centers for sickle cell disease.
Our mission is to improve clinical care of Sickle cell patients and improve their lives. A financial support will help us to build our access market strategy and our growth in Europe.

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

HORIZON-CSA - HORIZON Coordination and Support Actions

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) HORIZON-EIE-2021-SCALEUP-01

See all projects funded under this call

Coordinator

INNOVHEM
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 75 000,00
Address
4 RUE PIERRE FONTAINE
91000 Evry-Courcouronnes
France

See on map

Region
Ile-de-France Ile-de-France Essonne
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data
My booklet 0 0